Target RNA activates the protease activity of Craspase to confer antiviral defense

Xi Liu,Laixing Zhang,Hao Wang,Yu Xiu,Ling Huang,Zhengyu Gao,Ningning Li,Feixue Li,Weijia Xiong,Teng Gao,Yi Zhang,Maojun Yang,Yue Feng
DOI: https://doi.org/10.1016/j.molcel.2022.10.007
IF: 16
2022-01-01
Molecular Cell
Abstract:In the type III-E CRISPR-Cas system, a Cas effector (gRAMP) is associated with a TPR-CHAT to form Cras-pase (CRISPR-guided caspase). However, both the structural features of gRAMP and the immunity mecha-nism remain unknown for this system. Here, we report structures of gRAMP-crRNA and gRAMP:cRNA:target RNA as well as structures of Craspase and Craspase complexed with cognate target RNA (CTR) or non -cognate target RNA (NTR). Importantly, the 3' anti-tag region of NTR and CTR binds at two distinct channels in Craspase, and CTR with a non-complementary 3' anti-tag induces a marked conformational change of the TPR-CHAT, which allosterically activates its protease activity to cleave an ancillary protein Csx30. This cleav-age then triggers an abortive infection as the antiviral strategy of the type III-E system. Together, our study provides crucial insights into both the catalytic mechanism of the gRAMP and the immunity mechanism of the type III-E system.
What problem does this paper attempt to address?